Trichotillomania Clinical Trial
— OTTMOfficial title:
Developing Online Response Inhibition Training for Individuals With Trichotillomania
Verified date | October 2017 |
Source | University of Wisconsin, Milwaukee |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Trichotillomania (TTM) remains one of the most poorly-understood and inadequately-treated conditions. Research has shown poor response inhibition (RI; the ability to inhibit inappropriate but potent response) as an important cognitive feature of TTM. Investigators have developed a computerized training program that aims to improve RI. Fifty children with TTM will be randomly assigned to (a) online 8-session RI training (n=25), or (b) 1-month waitlist condition (n = 25), and will be assessed at baseline, post-treatment, and 1-month follow-up. Investigators hypothesize that the online RIT will show greater improvement in TTM symptoms and RI capabilities at post-treatment and 1-month follow-up assessments, compared to the waitlist condition. This study will help develop an effective cognitive intervention program for TTM.
Status | Completed |
Enrollment | 54 |
Est. completion date | June 2017 |
Est. primary completion date | June 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 17 Years |
Eligibility |
Inclusion Criteria: - age between 8 and 17 - a diagnosis of trichotillomania - a computer with high speed internet Exclusion Criteria: - current substance use problems - current or past psychotic disorder, bipolar disorder, or schizophrenia - current behavioral treatments for trichotillomania - significant suicidality - severe conditions known for poor response inhibition(ADHD, OCD, and tic disorders) - recent or planned change in medication - low intellectual functioning (below 80) |
Country | Name | City | State |
---|---|---|---|
United States | UWM Anxiety Disorders Laboratory | Milwaukee | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
University of Wisconsin, Milwaukee |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change on the Trichotillomania Scale for Children | This is a widely used self-report measure of hair pulling symptoms. Both the participant and parent will fill out this questionnaire at baseline, at 4 weeks, and at 1-month follow-up. | Baseline, 4 weeks, and 1-month Follow-up | |
Primary | Change on the NIMH Trichotillomania Severity and Impairment Scales | These are clinician-rated measures for assessing the severity of trichotillomania and the impairment caused by hair pulling. This measure will be administered at baseline, at 4 weeks, and at 1-month follow-up. | Baseline, 4 weeks, and 1-month Follow-up | |
Secondary | Change on the Clinical Global Impression Scale | This is a widely used brief assessment tool for evaluating illness severity, global improvement or change, and therapeutic response. This measure will be administered at baseline, at 4 weeks, and at 1-month follow-up. | Baseline, 4 weeks, and 1-month Follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01445444 -
Habit Reversal Training for Children and Adolescents With Trichotillomania
|
N/A | |
Completed |
NCT04559750 -
Internet CBT for Trichotillomania and Skin Picking Disorder
|
N/A | |
Completed |
NCT01638975 -
Response Inhibition Training for Individuals With Trichotillomania
|
N/A | |
Completed |
NCT00993265 -
N-Acetylcysteine for Pediatric Trichotillomania
|
Phase 2 | |
Completed |
NCT00917098 -
Examining Behavior Therapy for Trichotillomania in Children and Adolescents
|
N/A | |
Recruiting |
NCT00552266 -
Methylphenidate in ADHD With Trichotillomania
|
Phase 4 | |
Completed |
NCT03530800 -
Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors
|
Phase 2/Phase 3 | |
Completed |
NCT00740909 -
Cognitive Behavioral Therapy for Trichotillomania
|
Phase 1/Phase 2 | |
Recruiting |
NCT05003401 -
Leveraging Technological Advancements to Improve the Treatment of Trichotillomania
|
N/A | |
Completed |
NCT01875445 -
Inositol in Trichotillomania
|
Phase 2 | |
Completed |
NCT03486041 -
Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania
|
N/A | |
Completed |
NCT02473913 -
Milk Thistle in Trichotillomania in Children and Adults
|
Phase 2 | |
Completed |
NCT00872742 -
Testing a New Therapy for Trichotillomania
|
Phase 2 | |
Completed |
NCT00182507 -
Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
|
Phase 4 | |
Completed |
NCT00947154 -
Trial of Aripiprazole in Trichotillomania
|
N/A | |
Completed |
NCT00354770 -
N-Acetyl Cysteine in Trichotillomania
|
Phase 2 | |
Completed |
NCT00004550 -
Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions
|
N/A | |
Completed |
NCT01878110 -
Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of Trichotillomania
|
N/A | |
Active, not recruiting |
NCT01075672 -
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
|
N/A | |
Completed |
NCT01968343 -
Trichotillomania: Group Cognitive-Behavioral Therapy
|
Phase 2 |